Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study
Yin Wu,Linda Kwakkenbos,Richard S Henry,Marie-Eve Carrier,Maria Gagarine,Sami Harb,Angelica Bourgeault,Lydia Tao,Andrea Carboni-Jiménez,Zelalem Negeri,Scott Patten,Susan J Bartlett,Luc Mouthon,John Varga,Andrea Benedetti,Brett D Thombs,SPIN Patient Advisors,SPIN Investigators,Catherine Fortuné,Amy Gietzen,Geneviève Guillot,Nancy Lewis,Michelle Richard,Maureen Sauvé,Joep Welling,Kim Fligelstone,Karen Gottesman,Catarina Leite,Elisabet Pérez,Murray Baron,Vanessa Malcarne,Maureen D Mayes,Warren R Nielson,Robert Riggs,Shervin Assassi,Carolyn Ells,Cornelia van den Ende,Tracy Frech,Daphna Harel,Monique Hinchcliff,Marie Hudson,Sindhu R Johnson,Maggie Larche,Christelle Nguyen,Janet Pope,François Rannou,Tatiana Sofia Rodriguez Reyna,Anne A Schouffoer,Maria E Suarez-Almazor,Christian Agard,Alexandra Albert,Elana J Bernstein,Sabine Berthier,Lyne Bissonnette,Alessandra Bruns,Patricia Carreira,Benjamin Chaigne,Lorinda Chung,Chase Correia,Christopher Denton,Robyn Domsic,James V Dunne,Bertrand Dunogue,Dominique Farge-Bancel,Paul R Fortin,Jessica Gordon,Brigitte Granel-Rey,Pierre-Yves Hatron,Ariane L Herrick,Sabrina Hoa,Niall Jones,Artur Jose de B Fernandes,Suzanne Kafaja,Nader Khalidi,David Launay,Joanne Manning,Isabelle Marie,Maria Martin,Arsene Mekinian,Sheila Melchor,Mandana Nikpour,Louis Olagne,Susanna Proudman,Alexis Régent,Sébastien Rivière,David Robinson,Esther Rodriguez,Sophie Roux,Vincent Sobanski,Virginia Steen,Evelyn Sutton,Carter Thorne,Pearce Wilcox,Mara Cañedo Ayala,Julia Nordlund,Nora Østbø,Danielle B Rice,Kimberly A Turner,Nicole Culos-Reed,Laura Dyas,Ghassan El-Baalbaki,Shannon Hebblethwaite,Laura Bustamante,Delaney Duchek,Kelsey Ellis
DOI: https://doi.org/10.1016/j.jpsychores.2020.110314
Abstract:Introduction: No studies have examined factors associated with fear in any group of people vulnerable during COVID-19 due to pre-existing medical conditions. Objective: To investigate factors associated with fear of consequences of COVID-19 among people living with a pre-existing medical condition, the autoimmune disease systemic sclerosis (SSc; scleroderma), including country. Methods: Pre-COVID-19 data from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort were linked to COVID-19 data collected in April 2020. Multivariable linear regression was used to assess factors associated with continuous scores of the 10-item COVID-19 Fears Questionnaire for Chronic Medical Conditions, controlling for pre-COVID-19 anxiety symptoms. Results: Compared to France (N = 156), COVID-19 Fear scores among participants from the United Kingdom (N = 50) were 0.12 SD (95% CI 0.03 to 0.21) higher; scores for Canada (N = 97) and the United States (N = 128) were higher, but not statistically significant. Greater interference of breathing problems was associated with higher fears due to COVID-19 (Standardized regression coefficient = 0.12, 95% CI 0.01 to 0.23). Participants with higher financial resources adequacy scores had lower COVID-19 Fear scores (Standardized coefficient = -0.18, 95% CI -0.28 to -0.09). Conclusions: Fears due to COVID-19 were associated with clinical and functional vulnerabilities in this chronically ill population. This suggests that interventions may benefit from addressing specific clinical issues that apply to specific populations. Financial resources, health policies and political influences may also be important. The needs of people living with chronic illness during a pandemic may differ depending on the social and political context in which they live.